In an MHC IINEG myeloma model, secretion of tumor-specific myeloma protein clearly facilitates priming of APC in lymph nodes and stimulation of naive CD4+ T cells that subsequently infiltrate the tumor site. Here, CD4 is linked to neoplasm.